A significant industry trend in the Biological Polymerase Chain Reaction (PCR) Technology Market includes the Advancements In Digital PCR Assay Kits For Precise DNA And RNA Quantification
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Biological Polymerase Chain Reaction (PCR) Technology Market Between 2026 And 2030?
The market size for biological polymerase chain reaction (pcr) technology has experienced rapid growth in recent years. It is projected to expand from $16.62 billion in 2025 to reach $18.31 billion in 2026, showcasing a compound annual growth rate (CAGR) of 10.2%. Historically, this expansion can be attributed to several factors: the broader adoption of molecular diagnostics, the increasing use of pcr in infectious disease testing, the growth of genomic research activities, a rising demand for accurate nucleic acid amplification, and improvements in thermal cycler technologies.
The market size for biological polymerase chain reaction (PCR) technology is poised for substantial growth in the upcoming years. It is projected to expand to $26.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.9%. This anticipated expansion during the forecast period is driven by factors such as the increasing adoption of point-of-care PCR systems, the expanding utilization of PCR in oncology and genetic testing, the progression of personalized medicine, escalating investments in laboratory automation, and a heightened demand for rapid diagnostic solutions. Significant trends expected during this forecast period encompass the growing integration of real-time and digital PCR techniques, an increasing need for high-sensitivity molecular diagnostics, the wider adoption of PCR data analysis software, the broadening of multiplex and high-throughput PCR applications, and an intensified focus on workflow automation.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27223&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Biological Polymerase Chain Reaction (PCR) Technology Market?
The increasing occurrence of infectious diseases is projected to boost the expansion of the biological polymerase chain reaction (PCR) technology market in the future. These diseases are defined as ailments resulting from organisms like bacteria, viruses, fungi, or parasites. The growing frequency of infectious diseases is fueled by increased global travel, which aids in the quicker and broader dissemination of pathogens across various regions. Biological polymerase chain reaction (PCR) technology contributes to fighting infectious diseases through its capacity for swift and precise detection of pathogens, thereby supporting early diagnosis, prompt treatment, and efficient control of outbreaks. For example, in December 2024, the World Health Organization, an intergovernmental agency located in Switzerland, reported that malaria, a significant infectious disease, led to an estimated 263 million cases worldwide in 2023. This represented an increase of approximately 252 million from 2022. The case incidence was 60.4 per 1,000 population at risk, rising from 58.6 in 2022, and resulted in 597,000 deaths, with 94 percent of the cases and 95 percent of the fatalities concentrated in the WHO African Region. Consequently, the increasing prevalence of infectious diseases is stimulating the expansion of the biological polymerase chain reaction (PCR) technology market.
Which Market Segments Are Examined In The Biological Polymerase Chain Reaction (PCR) Technology Market Study?
The biological polymerase chain reaction (pcr) technology market covered in this report is segmented –
1) By Product Type: Reagents, Consumables, Software And Services
2) By Technique: Real-Time Polymerase Chain Reaction (PCR), Conventional Polymerase Chain Reaction (PCR), Digital Polymerase Chain Reaction (PCR), Reverse Transcription Polymerase Chain Reaction (PCR), Hot-Start Polymerase Chain Reaction (PCR), Multiplex Polymerase Chain Reaction (PCR), Other Polymerase Chain Reaction (PCR) Techniques
3) By Application: Diagnostic Applications, Genotyping, Nucleic Acid Detection, Gene Expression Analysis, Nucleic Acid Synthesis, Genetic Sequencing, Environmental Applications, Standard Validation Or Verification, Other Applications
4) By End User: Hospital Laboratories, Diagnostic Laboratories, Academic And Government Organizations, Pharma-Biotech Companies, Other End Users
Subsegments:
1) By Reagents: DNA Polymerase, DNTPs, Primers And Probes, Buffers And Master Mixes, Enzymes, Nucleic Acid Templates, Additives And Enhancers
2) By Consumables: PCR Tubes, PCR Plates, Sealing Films And Mats, Microplates, Reaction Vessels, Pipette Tips, PCR Strips
3) By Software And Services: PCR Data Analysis Software, Real-Time PCR Analysis Software, Cloud-Based Data Storage Solutions, PCR Workflow Management Tools, Technical Support Services, Calibration And Maintenance Services, Training And Consultation Services
What Trends Are Projected To Affect The Biological Polymerase Chain Reaction (PCR) Technology Market?
Leading companies in the biological polymerase chain reaction (PCR) technology market are prioritizing technological advancements, such as digital PCR assay kits, to enable precise and efficient quantification of DNA and RNA for biopharma research, cell and gene therapies, and food safety. Digital PCR assay kits are laboratory reagent kits utilized for highly sensitive and accurate DNA or RNA quantification using digital PCR technology. For example, in November 2023, QIAGEN, a Netherlands-based provider of molecular biology solutions, unveiled its QIAcuity Digital PCR Kits and an updated QIAcuity software to extend applications in biopharma and food-safety testing. These kits leverage optimized reagents and consumables to separate nucleic acid samples into thousands of nanoliter-scale reactions, facilitating the sensitive detection and quantification of rare variants or pathogens. The accompanying updated software offers automated analysis, workflow guidance, and data visualization, simplifying interpretation. Key features include superior sensitivity, a broad dynamic range, multiplexing capabilities, and straightforward operation. Their applications encompass gene expression analysis, mutation detection, microbial testing, and quality control, providing enhanced accuracy, reduced hands-on time, and reliable low-copy detection across various research and regulatory settings.
Who Are The Primary Competitors In The Biological Polymerase Chain Reaction (PCR) Technology Market?
Major companies operating in the biological polymerase chain reaction (pcr) technology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Cepheid Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena GmbH+Co. KG, New England Biolabs Inc., Enzo Biochem Inc., LGC Biosearch Technologies Inc., Bioline Reagents Ltd., Illumina Inc., Abbott Laboratories
Read the full biological polymerase chain reaction (pcr) technology market report here:
What Are The Leading Geographic Regions In The Biological Polymerase Chain Reaction (PCR) Technology Market?
North America was the largest region in the biological polymerase chain reaction (PCR) technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological polymerase chain reaction (pcr) technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Biological Polymerase Chain Reaction (PCR) Technology Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27223&type=smp
Browse Through More Reports Similar to the Global Biological Polymerase Chain Reaction (PCR) Technology Market 2026, By The Business Research Company
Hydrocolloids Global Market Report
https://www.thebusinessresearchcompany.com/report/hydrocolloids-global-market-report
Hydrocortisone Global Market Report
https://www.thebusinessresearchcompany.com/report/hydrocortisone-global-market-report
Food Hydrocolloids Global Market Report
https://www.thebusinessresearchcompany.com/report/food-hydrocolloids-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
